This handout is for geriatric infection syndromes overlay — atypical presentation, blunted fever, uti stewardship in older adults. Your care team identified this based on: age ≥ 65 with suspected infection (fever / delirium / functional decline / falls / non-specific decline) — geriatric overlay anchor (norman j am geriatr soc 2000 pmid 10968297).
Other reasons your team may use this plan: acute change in cognition / inattention / disorganised thinking / altered level of consciousness in older adult — cam / 4at positive → infection workup (inouye nejm 2006 pmid 16540616; bellelli 4at 2014); acute loss of adls / inability to perform prior activities / new dependence in older adult — infection workup (bellelli age ageing 2014; geriatric acute illness presentation framework); new / recurrent falls in older adult without clear mechanical cause — lower threshold for occult infection workup (uti / pneumonia / cholecystitis / appendicitis).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| ceftriaxone | 1-2 g IV q24h (no renal adjustment unless CrCl < 10) | IV | daily | IDSA Hooton 2010 + standard for pyelonephritis in older adult; preserved renal function not required |
| cefepime | 2 g IV q8-12h with renal adjustment per CrCl (1 g q24h if CrCl 11-29; 500 mg q24h if CrCl ≤ 10) | IV | q8-12h | IDSA Hooton 2010 + IDSA/ATS 2016 Kalil for HCA-spectrum; cefepime neurotoxicity in older adult with renal impairment — dose-adjust strictly per CrCl |
| nitrofurantoin | 100 mg PO BID × 5-7 d (uncomplicated cystitis only) | PO | BID | AGS Beers 2023 — AVOID if CrCl < 30 (inadequate urinary concentrations + pulmonary / hepatic toxicity in long-term suppression). Acceptable if CrCl ≥ 30 for short-course uncomplicated cystitis |
| trimethoprim-sulfamethoxazole | 160-800 mg PO BID × 3 d (uncomplicated cystitis) | PO | BID | IDSA Gupta 2011 + AGS Beers 2023 — caution with renal impairment + hyperkalemia + warfarin DDI; use only if susceptible |
| ciprofloxacin | 500 mg PO BID OR 400 mg IV q12h × 7 d | PO/IV | BID | AGS Beers 2023 — AVOID for uncomplicated UTI when alternatives available (delirium / tendinopathy / QTc / aortic dissection risks). DailyMed fluoroquinolone black box. Reserve for culture-directed when no alternative |
Plan: Geriatric infection empiric antibiotics — by source × Beers/STOPP review × renal dose-adjustment
Contact your care team if any of the following happen:
Call 911 or go to the nearest emergency room right away if you have:
Post-hospital syndrome surveillance (delirium recovery, functional restoration, sarcopenia screening); caregiver education on signs of recurrence; advance care planning + POLST update; vaccination (PCV20, influenza, COVID-19, herpes zoster per ACIP 2024); STOPP/START re-review at 4-6 wk; outpatient geriatrics follow-up; SNF / hospital-at-home coordination if applicable.
Guideline: IDSA Nicolle 2019 Asymptomatic Bacteriuria guideline (PMID 30895288) + AGS Beers Criteria 2023 + STOPP/START v3 2023 (O'Mahony Age Ageing 2023) + Loeb 2001 SNF UTI minimum criteria (PMID 11380742) + Norman 2000 fever in elderly (PMID 10968297) + Inouye 2006 delirium NEJM (PMID 16540616) + Bellelli 4AT 2014 + Rockwood 2005 Clinical Frailty Scale (PMID 16129869) + Fried 2001 frailty phenotype (PMID 11253156) + ATS/IDSA Metlay 2019 CAP (PMID 31573350) + IDSA Stevens 2014 SSTI (PMID 24973422) + Mid-Atlantic Stewardship Network 2022 antibiotic-stewardship-for-the-elderly + NICE NG144 catheter UTI + SSC 2026 sepsis bundle